Biomedical Engineering Reference
In-Depth Information
Simard, P. & Leroux, J. C. (2010) In vivo evaluation of pH-sensitive polymer-based immunolipo-
somes targeting the CD33 antigen.
Mol Pharm
, 7, 1098-107.
Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser,
D., Weiner, D. B., Shankar, P., Marasco, W. A. & Lieberman, J. (2005) Antibody mediated
in vivo delivery of small interfering RNAs via cell-surface receptors.
Nat Biotechnol
,
23, 709-17.
Soundararajan, S., Chen, W., Spicer, E. K., Courtenay-Luck, N. & Fernandes, D. J. (2008) The
nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast can-
cer cells.
Cancer Res
, 68, 2358-65.
Stern, R., Asari, A. A. & Sugahara, K. N. (2006) Hyaluronan fragments: an information-rich
system.
Eur J Cell Biol
, 85, 699-715.
Strebhardt, K. & Ullrich, A. (2008) Paul Ehrlich's magic bullet concept: 100 years of progress.
Nat Rev Cancer
, 8, 473-80.
Sudimack, J. & Lee, R. J. (2000) Targeted drug delivery via the folate receptor.
Adv Drug Deliv
Rev
, 41, 147-62.
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan,
D., Mattrey, R. F. & Ruoslahti, E. (2009) Tissue-penetrating delivery of compounds and nano-
particles into tumors.
Cancer Cell
, 16, 510-20.
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R. &
Ruoslahti, E. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of
cancer drugs.
Science
, 328, 1031-5.
Suh, W., Chung, J. K., Park, S. H. & Kim, S. W. (2001) Anti-JL1 antibody-conjugated poly
(L-lysine) for targeted gene delivery to leukemia T cells.
J Control Release
, 72, 171-8.
Tacken, P. J., de Vries, I. J., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J.,
Torensma, R., Adema, G. J. & Figdor, C. G. (2005) Effective induction of naive and recall
T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN
antibody.
Blood
, 106, 1278-85.
Taghdisi, S. M., Abnous, K., Mosaffa, F. & Behravan, J. (2009) Targeted delivery of daunorubicin
to T-cell acute lymphoblastic leukemia by aptamer.
J Drug Target
.
Tasch, J., Gong, M., Sadelain, M. & Heston, W. D. (2001) A unique folate hydrolase, prostate-
specific membrane antigen (PSMA): a target for immunotherapy?
Crit Rev Immunol
,
21, 249-61.
Torchilin, V. P. (2006) Multifunctional nanocarriers.
Adv Drug Deliv Rev
, 58, 1532-55.
Torchilin, V. P. (2010) Passive and active drug targeting: drug delivery to tumors as an example.
Handb Exp Pharmacol
, 3-53.
Turner, J. J., Jones, S., Fabani, M. M., Ivanova, G., Arzumanov, A. A. & Gait, M. J. (2007) RNA
targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
Blood Cells Mol Dis
,
38, 1-7.
Ugolini, S., Mondor, I. & Sattentau, Q. J. (1999) HIV-1 attachment: another look.
Trends
Microbiol
, 7, 144-9.
Vilner, B. J., John, C. S. & Bowen, W. D. (1995) Sigma-1 and sigma-2 receptors are expressed in
a wide variety of human and rodent tumor cell lines.
Cancer Res
, 55, 408-13.
Vives, E., Brodin, P. & Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly
translocates through the plasma membrane and accumulates in the cell nucleus.
J Biol Chem
,
272, 16010-7.
von Eckardstein, A., Nofer, J. R. & Assmann, G. (2001) High density lipoproteins and arterioscle-
rosis. Role of cholesterol efflux and reverse cholesterol transport.
Arterioscler Thromb Vasc
Biol
, 21, 13-27.
Wadia, J. S., Stan, R. V. & Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances
escape of TAT-fusion proteins after lipid raft macropinocytosis.
Nat Med
, 10, 310-5.
Wang, S., Lee, R. J., Mathias, C. J., Green, M. A. & Low, P. S. (1996) Synthesis, purification, and
tumor cell uptake of 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor
imaging.
Bioconjug Chem
, 7, 56-62.
Search WWH ::
Custom Search